The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nucleic Acid Delivery Excipients Market Research Report 2025
Synopsis
Nucleic acids, including plasmid DNA, oligonucleotides, small interfering RNA, messenger RNA and micro RNA provide significant promise in the treatment of challenging diseases. Unfortunately, their delivery as therapeutic agents has been a challenge. Nanoparticulate delivery systems, in which cationic lipids or polymers condense nucleic acids to form “lipoplex” or “polyplex” via the negative phosphate groups of nucleic acids show high productivity and loading efficiency. The intracellular delivery of these complexes is believed to occur via endocytosis followed by endosomal escape into the cytoplasm.
Global Nucleic Acid Delivery Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Delivery Excipients market research.
Key manufacturers engaged in the Nucleic Acid Delivery Excipients industry include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nucleic Acid Delivery Excipients were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Delivery Excipients market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Segment by Application
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nucleic Acid Delivery Excipients report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Nucleic acids, including plasmid DNA, oligonucleotides, small interfering RNA, messenger RNA and micro RNA provide significant promise in the treatment of challenging diseases. Unfortunately, their delivery as therapeutic agents has been a challenge. Nanoparticulate delivery systems, in which cationic lipids or polymers condense nucleic acids to form “lipoplex” or “polyplex” via the negative phosphate groups of nucleic acids show high productivity and loading efficiency. The intracellular delivery of these complexes is believed to occur via endocytosis followed by endosomal escape into the cytoplasm.
Global Nucleic Acid Delivery Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Delivery Excipients market research.
Key manufacturers engaged in the Nucleic Acid Delivery Excipients industry include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nucleic Acid Delivery Excipients were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Delivery Excipients market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Segment by Application
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nucleic Acid Delivery Excipients report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Nucleic Acid Delivery Excipients Market Overview
1.1 Product Overview and Scope of Nucleic Acid Delivery Excipients
1.2 Nucleic Acid Delivery Excipients Segment by Type
1.2.1 Global Nucleic Acid Delivery Excipients Market Value Comparison by Type (2023-2029)
1.2.2 Cationic Lipids
1.2.3 pH-sensitive Lipids
1.2.4 Phospholipids
1.2.5 PEG Lipids
1.3 Nucleic Acid Delivery Excipients Segment by Application
1.3.1 Global Nucleic Acid Delivery Excipients Market Value by Application: (2023-2029)
1.3.2 Lipid Nanoparticles for mRNA/siRNA/DNA
1.3.3 Transfection Vectors for Gene Therapies
1.3.4 Immunotherapies (CAR-T-Cells)
1.3.5 Lipid Prodrugs
1.3.6 Liposome Vectorization for Oncology
1.3.7 Others
1.4 Global Nucleic Acid Delivery Excipients Market Size Estimates and Forecasts
1.4.1 Global Nucleic Acid Delivery Excipients Revenue 2018-2029
1.4.2 Global Nucleic Acid Delivery Excipients Sales 2018-2029
1.4.3 Global Nucleic Acid Delivery Excipients Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nucleic Acid Delivery Excipients Market Competition by Manufacturers
2.1 Global Nucleic Acid Delivery Excipients Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nucleic Acid Delivery Excipients Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nucleic Acid Delivery Excipients Average Price by Manufacturers (2018-2023)
2.4 Global Nucleic Acid Delivery Excipients Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nucleic Acid Delivery Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nucleic Acid Delivery Excipients, Product Type & Application
2.7 Nucleic Acid Delivery Excipients Market Competitive Situation and Trends
2.7.1 Nucleic Acid Delivery Excipients Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nucleic Acid Delivery Excipients Players Market Share by Revenue
2.7.3 Global Nucleic Acid Delivery Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nucleic Acid Delivery Excipients Retrospective Market Scenario by Region
3.1 Global Nucleic Acid Delivery Excipients Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nucleic Acid Delivery Excipients Global Nucleic Acid Delivery Excipients Sales by Region: 2018-2029
3.2.1 Global Nucleic Acid Delivery Excipients Sales by Region: 2018-2023
3.2.2 Global Nucleic Acid Delivery Excipients Sales by Region: 2024-2029
3.3 Global Nucleic Acid Delivery Excipients Global Nucleic Acid Delivery Excipients Revenue by Region: 2018-2029
3.3.1 Global Nucleic Acid Delivery Excipients Revenue by Region: 2018-2023
3.3.2 Global Nucleic Acid Delivery Excipients Revenue by Region: 2024-2029
3.4 North America Nucleic Acid Delivery Excipients Market Facts & Figures by Country
3.4.1 North America Nucleic Acid Delivery Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nucleic Acid Delivery Excipients Sales by Country (2018-2029)
3.4.3 North America Nucleic Acid Delivery Excipients Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nucleic Acid Delivery Excipients Market Facts & Figures by Country
3.5.1 Europe Nucleic Acid Delivery Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nucleic Acid Delivery Excipients Sales by Country (2018-2029)
3.5.3 Europe Nucleic Acid Delivery Excipients Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nucleic Acid Delivery Excipients Market Facts & Figures by Country
3.6.1 Asia Pacific Nucleic Acid Delivery Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nucleic Acid Delivery Excipients Sales by Country (2018-2029)
3.6.3 Asia Pacific Nucleic Acid Delivery Excipients Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nucleic Acid Delivery Excipients Market Facts & Figures by Country
3.7.1 Latin America Nucleic Acid Delivery Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nucleic Acid Delivery Excipients Sales by Country (2018-2029)
3.7.3 Latin America Nucleic Acid Delivery Excipients Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nucleic Acid Delivery Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Nucleic Acid Delivery Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nucleic Acid Delivery Excipients Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nucleic Acid Delivery Excipients Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nucleic Acid Delivery Excipients Sales by Type (2018-2029)
4.1.1 Global Nucleic Acid Delivery Excipients Sales by Type (2018-2023)
4.1.2 Global Nucleic Acid Delivery Excipients Sales by Type (2024-2029)
4.1.3 Global Nucleic Acid Delivery Excipients Sales Market Share by Type (2018-2029)
4.2 Global Nucleic Acid Delivery Excipients Revenue by Type (2018-2029)
4.2.1 Global Nucleic Acid Delivery Excipients Revenue by Type (2018-2023)
4.2.2 Global Nucleic Acid Delivery Excipients Revenue by Type (2024-2029)
4.2.3 Global Nucleic Acid Delivery Excipients Revenue Market Share by Type (2018-2029)
4.3 Global Nucleic Acid Delivery Excipients Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nucleic Acid Delivery Excipients Sales by Application (2018-2029)
5.1.1 Global Nucleic Acid Delivery Excipients Sales by Application (2018-2023)
5.1.2 Global Nucleic Acid Delivery Excipients Sales by Application (2024-2029)
5.1.3 Global Nucleic Acid Delivery Excipients Sales Market Share by Application (2018-2029)
5.2 Global Nucleic Acid Delivery Excipients Revenue by Application (2018-2029)
5.2.1 Global Nucleic Acid Delivery Excipients Revenue by Application (2018-2023)
5.2.2 Global Nucleic Acid Delivery Excipients Revenue by Application (2024-2029)
5.2.3 Global Nucleic Acid Delivery Excipients Revenue Market Share by Application (2018-2029)
5.3 Global Nucleic Acid Delivery Excipients Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Avanti Polar Lipids
6.1.1 Avanti Polar Lipids Corporation Information
6.1.2 Avanti Polar Lipids Description and Business Overview
6.1.3 Avanti Polar Lipids Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Avanti Polar Lipids Nucleic Acid Delivery Excipients Product Portfolio
6.1.5 Avanti Polar Lipids Recent Developments/Updates
6.2 Alfa Chemistry
6.2.1 Alfa Chemistry Corporation Information
6.2.2 Alfa Chemistry Description and Business Overview
6.2.3 Alfa Chemistry Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Alfa Chemistry Nucleic Acid Delivery Excipients Product Portfolio
6.2.5 Alfa Chemistry Recent Developments/Updates
6.3 Evonik Health Care
6.3.1 Evonik Health Care Corporation Information
6.3.2 Evonik Health Care Description and Business Overview
6.3.3 Evonik Health Care Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Evonik Health Care Nucleic Acid Delivery Excipients Product Portfolio
6.3.5 Evonik Health Care Recent Developments/Updates
6.4 Phosphorex
6.4.1 Phosphorex Corporation Information
6.4.2 Phosphorex Description and Business Overview
6.4.3 Phosphorex Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Phosphorex Nucleic Acid Delivery Excipients Product Portfolio
6.4.5 Phosphorex Recent Developments/Updates
6.5 Creative Biolabs
6.5.1 Creative Biolabs Corporation Information
6.5.2 Creative Biolabs Description and Business Overview
6.5.3 Creative Biolabs Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Creative Biolabs Nucleic Acid Delivery Excipients Product Portfolio
6.5.5 Creative Biolabs Recent Developments/Updates
6.6 Celares
6.6.1 Celares Corporation Information
6.6.2 Celares Description and Business Overview
6.6.3 Celares Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Celares Nucleic Acid Delivery Excipients Product Portfolio
6.6.5 Celares Recent Developments/Updates
6.7 VectorBuilder
6.6.1 VectorBuilder Corporation Information
6.6.2 VectorBuilder Description and Business Overview
6.6.3 VectorBuilder Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.4.4 VectorBuilder Nucleic Acid Delivery Excipients Product Portfolio
6.7.5 VectorBuilder Recent Developments/Updates
6.8 Seqens
6.8.1 Seqens Corporation Information
6.8.2 Seqens Description and Business Overview
6.8.3 Seqens Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Seqens Nucleic Acid Delivery Excipients Product Portfolio
6.8.5 Seqens Recent Developments/Updates
6.9 BroadPharm
6.9.1 BroadPharm Corporation Information
6.9.2 BroadPharm Description and Business Overview
6.9.3 BroadPharm Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BroadPharm Nucleic Acid Delivery Excipients Product Portfolio
6.9.5 BroadPharm Recent Developments/Updates
6.10 Entos
6.10.1 Entos Corporation Information
6.10.2 Entos Description and Business Overview
6.10.3 Entos Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Entos Nucleic Acid Delivery Excipients Product Portfolio
6.10.5 Entos Recent Developments/Updates
6.11 Gattefossé
6.11.1 Gattefossé Corporation Information
6.11.2 Gattefossé Nucleic Acid Delivery Excipients Description and Business Overview
6.11.3 Gattefossé Nucleic Acid Delivery Excipients Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Gattefossé Nucleic Acid Delivery Excipients Product Portfolio
6.11.5 Gattefossé Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nucleic Acid Delivery Excipients Industry Chain Analysis
7.2 Nucleic Acid Delivery Excipients Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nucleic Acid Delivery Excipients Production Mode & Process
7.4 Nucleic Acid Delivery Excipients Sales and Marketing
7.4.1 Nucleic Acid Delivery Excipients Sales Channels
7.4.2 Nucleic Acid Delivery Excipients Distributors
7.5 Nucleic Acid Delivery Excipients Customers
8 Nucleic Acid Delivery Excipients Market Dynamics
8.1 Nucleic Acid Delivery Excipients Industry Trends
8.2 Nucleic Acid Delivery Excipients Market Drivers
8.3 Nucleic Acid Delivery Excipients Market Challenges
8.4 Nucleic Acid Delivery Excipients Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
